"intercept" "in pathway" "intercept" "experimental" "in clinical development" "targeted" "unknown" "lambdaf" "lambdad"
"NIG1" 3.30372062684922 NA 757.822005197533 NA NA NA NA 2.88936338208976 0.30429946512457
"NIG2" 3.6753757291649 -1.41582340092758 672.084952975674 128.295485338096 30.7730693890112 -55.4988992665673 55.6333613728191 3.21273850890802 0.627708680716571
"NIG3" 103.383466756444 -28.7207958638438 NA NA NA NA NA 0.0452294502367098 NA
"NIG4" NA NA 623.390859054874 69.1089093300484 -42.6762654144086 276.394900627381 389.935504772583 NA 0.627708680716571
"NIG5" 3.6753757291649 -1.41582340092758 672.084952975674 128.295485338096 30.7730693890112 -55.4988992665673 55.6333613728191 3.21273850890802 0.627708680716571
"ridge" 3618.36819842422 -635.257575130639 NA NA NA NA NA NA NA
